Foresight Diagnostics (a Natera company) Employee Directory
Biotechnology ResearchColorado, United States51-200 Employees
Foresight Diagnostics is a Boulder, Colorado-based biotechnology research company founded by four Stanford University physicians and scientists to advance circulating tumor DNA testing. Its product, Foresight CLARITY, relies on a proprietary phased variant detection method and enhanced bioinformatics to improve detection limits and the accuracy of ctDNA tests and minimal residual disease measurements. The company operates a CLIA-certified laboratory, reflecting its role in delivering clinically oriented molecular diagnostics. In December 2025, Foresight Diagnostics was acquired by Natera, integrating its ctDNA testing capabilities into a larger diagnostic platform. The focus is on cancer diagnostics, serving settings that rely on ctDNA-based measurements to inform treatment decisions and monitor disease status.